VEVYE
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for VEVYE, covering 2023-05-30 to 2026-01-26. Get the full timeline:
Most recent: Clinical Trial Update: Comparison of Conjunctival Goblet Cell Density in Dry Eye Patients Treated With Cyclosporine 0.1% Dissolved in Perfluorobutylpentane (Vevye®) or Generic 0.05% Cyclosporine Emulsion for 8 Weeks [Phase 4]